Singing River ENT and Sleep Medicine are now offering Inspire therapy, a breakthrough treatment for Obstructive Sleep Apnea (OSA.) The innovative therapy caters to individuals unable to utilize Continuous Positive Airway Pressure (CPAP), providing a lifeline for those suffering from OSA. Dr. Erik Rasmussen, Otolaryngologist/ENT at Singing River, has achieved a significant milestone in sleep therapy by successfully performing the first-ever Inspire procedure at Singing River Pascagoula Hospital.
OSA affects 22 million Americans and poses serious risks, including accidents, mood and memory deterioration, stroke, heart attack, and even death when left untreated. This disruptive cycle of interrupted breathing during sleep results from the collapse of the airway, limiting oxygen flow to the brain.
Dr. Rasmussen expressed enthusiasm about the first Inspire case at Singing River Pascagoula, stating, “This achievement signifies a remarkable step forward in treating sleep apnea. Inspire is clinically proven to reduce sleep apnea events, and has a high level of patient satisfaction and a high therapy adherence. We are excited to offer this promising therapy to sleep apnea patients who struggle with CPAP.”
Singing River ENT and Sleep Medicine remain committed to advancing patient care and are now at the forefront of providing this innovative solution for sleep disorders. The successful completion of the first Inspire procedure at Singing River Pascagoula Hospital underscores the commitment to introducing cutting-edge therapies and enhancing the well-being of individuals affected by sleep apnea.
For more information about Inspire therapy, please visit InspireSleep.com or SingingRiverHealthSystem.com.